melatonin neurim
rad neurim pharmaceuticals eec sarl - melatonin - schlaf initiation und wartung störungen - psycholeptika - melatonin neurim is indicated as monotherapy for the short-term treatment of primary insomnia characterised by poor quality of sleep in patients who are aged 55 or over.
enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - vorläuferzelle lymphoblastische leukämie-lymphom - antineoplastische mittel - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
carbidopa/levodopa sandoz cr 25/100 retardtabletten
sandoz pharmaceuticals ag - carbidopum, levodopum - retardtabletten - carbidopum 25.00 mg ut carbidopum monohydricum, levodopum 100.00 mg, hypromellosum, silica colloidalis anhydrica, acidum fumaricum, natrii stearylis fumaras corresp. natrium 0.235 mg, e 104, Überzug: hypromellosum, macrogolum 6000, e 172 (flavum), e 172 (rubrum), e 171, pro compresso obducto. - morbus parkinson - synthetika
carbidopa/levodopa sandoz cr 50/200 retardtabletten
sandoz pharmaceuticals ag - carbidopum, levodopum - retardtabletten - carbidopum 50.00 mg ut carbidopum monohydricum, levodopum 200.00 mg, hypromellosum, silica colloidalis anhydrica, acidum fumaricum, natrii stearylis fumaras corresp. natrium 0.47 mg, e 104, Überzug: hypromellosum, macrogolum 6000, e 172 (flavum), e 172 (rubrum), e 171, pro compresso obducto. - morbus parkinson - synthetika
rasagilin bluefish 1 mg tabletten
bluefish pharmaceuticals ab (publ) (8093076) - rasagilintartrat - tablette - rasagilintartrat (43076) 1,438 milligramm
estalis 50/140 transdermale pflaster
sandoz pharmaceuticals ag - estradiolum, norethisteroni acetas - transdermale pflaster - estradiolum 0.60 mg estradiolum hemihydricum 0.62 mg, norethisteroni acetas 2.7 mg, silikon-kleber, acryl-kleber, povidonum k 30, säure oleicum, dipropylenglycolum, trägermaterial: die vorbereitung für die 9 cm2, mit der befreiung von 50 µg 140 µg/24 h auf. - oestrogen-gestagen-substitutionstherapie nach der menopause - synthetika
estalis 50/250 transdermale pflaster
sandoz pharmaceuticals ag - estradiolum, norethisteroni acetas - transdermale pflaster - estradiolum 0.496 mg estradiolum hemihydricum 0.512 mg, norethisteroni acetas 4.8 mg, silikon-kleber, acryl-kleber, povidonum k 30, säure oleicum, dipropylenglycolum, trägermaterial: die vorbereitung für die 16 cm2, mit der befreiung von 50 µg und 250 µg/24 h auf. - oestrogen-gestagen-substitutionstherapie nach der menopause - synthetika
co-ramipril sandoz 2.5/12.5 tabletten
sandoz pharmaceuticals ag - ramiprilum, hydrochlorothiazidum - tabletten - ramiprilum 2.5 mg, hydrochlorothiazidum 12.5 mg, natrii hydrogenocarbonas, hypromellosum, cellulosum microcristallinum, amylum pregelificatum, natrii stearylis fumaras, pro compresso, natrium 0.5589 mg. - antihypertensivum - synthetika
co-ramipril sandoz 5/25 tabletten
sandoz pharmaceuticals ag - ramiprilum, hydrochlorothiazidum - tabletten - ramiprilum 5 mg, hydrochlorothiazidum 25 mg, natrii hydrogenocarbonas, hypromellosum, cellulosum microcristallinum, amylum pregelificatum, natrii stearylis fumaras, pro compresso, natrium 1.1178 mg. - antihypertensivum - synthetika
lamotrigin sandoz 25 tabletten
sandoz pharmaceuticals ag - lamotriginum - tabletten - lamotriginum 25 mg, calcii carbonas, sorbitolum 2.89 mg, cellulosum microcristallinum silicificatum, crospovidonum, maydis amylum, talcum, natrii stearylis fumaras, silica colloidalis anhydrica, aromatica, saccharinum natricum pro compresso corresp. natrium 0.206 mg. - antiepilepticum - synthetika